It is now clear that G-protein-coupled receptors can regulate programmed cell death (apoptosis) through a variety of mechanisms that are dependent on cell type and receptor subtype. Here we present evidence that the G q/11 -coupled subtypes of the muscarinic receptor family (namely M 1 , M 3 and M 5 -muscarinic receptor subtypes) are able to protect against apoptotic cell death. In particular we demonstrate that the C-terminal tail of the M 3 -muscarinic receptor is an essential structural element for signalling to the anti-apoptotic pathway. Removal of the distal portion of the C-terminal tail results in a receptor that is coupled normally to the G q/11 /phospholipase C pathway and the mitogen-activated protein kinase pathway, but is unable to couple to the anti-apoptotic pathway. Furthermore, a poly-basic region conserved within the C-terminal tail of the G q/11 -coupled muscarinic receptor subtypes appears to be the structural determinant of coupling to the anti-apoptotic pathway.
Introduction
Apoptosis is characterized by the activation of a specific intracellular cysteine protease cascade that results in the breakdown of the cell cytoskeleton, destruction of the integrity of the nucleus and cleavage of cellular DNA, leading ultimately to cell death. These proteases, called caspases, can be activated following the occupation of certain cellsurface 'death' receptors (e.g. the Fas receptor or tumour necrosis factor receptor) or by agents that induce stress or DNA damage [1, 2] . In the case of DNA-damaging agents such as the topoisomerase II inhibitor etoposide, caspase activation follows a defined biochemical pathway. The key feature of this pathway is the balance between the pro-and anti-apoptotic Bcl-2 proteins in the outer mitrochondrial membrane [3] . Pro-apoptotic Bcl-2 proteins, for example Bax and Bad, are held within the cytoplasm of non-apoptotic cells. Apoptotic stimuli can result in the translocation of these proteins to the outer mitrochondrial membrane where they increase membrane permeability in a manner that allows for the release of cytochrome c into the cytoplasm [4] [5] [6] . Cytochrome c can then form a complex with apoptotic proteaseactivating factor 1 and caspase-9 [7] . This complex, known as the apoptosome, initiates the auto-catalytic activation of caspase-9 and the subsequent activation of the downstream caspase cascade. This apoptotic process can be inhibited by anti-apoptotic Bcl-2 proteins such as Bcl-2 itself and Bcl-x L [5] . These proteins prevent the formation of the mitoKey words: anti-apoptotic pathway, apoptosis, G-protein-coupled receptor, Gq/11-coupled muscarinic receptor, muscarinic receptor. Abbreviations used: GPCR, G-protein-coupled receptor; MAP kinase, mitogen-activated protein kinase; PI 3-kinase, phosphoinositide 3-kinase; PLC, phospholipase C; CHO, Chinese hamster ovary. 1 To whom correspondence should be addressed (e-mail tba@le.ac.uk).
chondrial permeability transition pore and thereby the release of cytochrome c and the formation of the apoptosome. Hence, one of the key features in cell survival is the balance between the expression levels of pro-and anti-apoptotic Bcl-2 proteins and the translocation of the pro-apoptotic Bcl-2 proteins to the mitrochondrial membrane.
It has now become clear that a number of GPCRs (Gprotein-coupled receptors) can regulate apoptotic signalling [8, 9] . For example, β-adrenergic stimulation in cardiac myocytes promotes apoptosis via a mechanism that may involve the dephosphorylation of the pro-apoptotic protein, Bad, and in so doing initiate its translocation to the mitochondria [10, 11] . Further, transgenic mice in which the genes for visual arrestin or rhodopsin kinase have been knocked out show pronounced light-induced photoreceptor apoptosis resulting from the inability of rhodopsin to desensitize [12, 13] . In contrast with these pro-apoptotic effects, many GPCRs have now been shown to protect against apoptosis induced by growth factor withdrawal, DNA damage and/or cell stress. Among these receptors are the muscarinic receptors, which have been shown to protect against apoptosis in a number of clonal neuronal cell lines and primary neuronal preparations [14] [15] [16] [17] [18] . These observations have prompted speculation that cell survival mediated by muscarinic receptors may be important during neuronal development and that lesions in cholinergic pathways in neuro-degenerative diseases such as Alzheimer's disease may contribute to the loss of a survival stimulus and hence the progressive neuronal cell death which is a characteristic of these diseases.
Our recent studies have focused on the signalling mechanisms of the muscarinic receptor anti-apoptotic response and in particular on the structural domains of the receptor that are important in coupling the receptor to the antiapoptotic pathway. treated with carbachol (1 mM) and/or etoposide (250 µM) overnight and cell lysates processed for caspase activity using cleavage of the peptide substrate DEVD, which can be monitored by an increase in absorbance at 405 nm (for details, see [20] ). Data are normalized to 100% caspase activity in the presence of etoposide alone. Data shown are means ± S.E.M. (n = 3-6).
Role of muscarinic receptors in cell survival
The muscarinic receptor family comprises five gene members encoding receptors designated M 1 -M 5 , where M 1 , M 3 and M 5 couple to PLC (phospholipase C) via G q/11 proteins and M 2 and M 4 couple to the inhibition of adenylate cyclase via G i proteins [19] . Experiments carried out in our laboratory have determined that CHO (Chinese hamster ovary) cells transfected with the human M 3 -muscarinic receptor (CHO-M 3 cells) cultured in the presence of the DNAdamaging agent etoposide (250 µM for 16-24 h) undergo apoptotic cell death [20] . However, treatment of the CHO-M 3 cells with the cholinergic agonist carbachol can dramatically attenuate cell death (Figure 1) . This process appears to be specific to the G q/11 -coupled muscarinic receptor subtypes, since protection is clearly observed with M 1 -, M 3 -and M 5 -muscarinic receptors, but not M 2 -and M 4 -receptor subtypes (Figure 1 ).
Defining the role of the C-terminal tail of the M 3 -muscarinic receptor
Structure-function studies focused on the role of the Cterminal tail of the M 3 -muscarinic receptor. It was found that truncation of the C-tail at residue 565 ( 565-M 3 ) resulted in a receptor that was unable to mediate protection against etoposide-induced cell death (Figure 2) . Surprisingly, this receptor maintained its ability to couple, as efficiently as the wild-type receptor, to G q/11 /PLC signalling and the MAP kinase (mitogen-activated protein kinase) pathways involving extracellular-signal-regulated kinases 1/2 and c-Jun N-terminal kinase. It was therefore concluded that activation of these intracellular signalling pathways alone was not sufficient to mediate the anti-apoptotic response. This was unexpected since there is strong evidence demonstrating a role for these signalling pathways in regulating apoptotic responses [21] [22] [23] [24] [25] . Our findings were, however, confirmed by the lack effect of inhibitors to PLC (U73122) and MEK (PD98059) on the wild-type muscarinic receptor response [20] . Furthermore, the p38 MAP kinase inhibitor SB202190 also had no effect on the wild-type M 3 -muscarinic receptor anti-apoptotic response. A further candidate pathway in mediating the M 3 -muscarinic receptor anti-apoptotic response is the PI 3-kinase (phosphoinositide 3-kinase)/Akt pathway. This pathway has been strongly implicated in the survival responses of a number of GPCRs including recombinant muscarinic receptors expressed in COS-7 cells [26] . However, the involvement of this pathway in the protective response in CHO-M 3 cells appears unlikely since inhibition of PI 3-kinase with wortmannin (10 µM) had no effect on the muscarinic receptor protective response.
M 3 -muscarinic receptors up-regulate Bcl-2 levels in apoptotic cells
Investigation of the ability of the M 3 -muscarinic receptor to mediate changes in gene transcription was investigated by determination of the incorporation of [ 3 H]UTP into RNA isolated from CHO-M 3 cells. Receptor stimulation resulted in a rapid increase in RNA synthesis evident after 30 s of receptor activation and maintained for at least 1 h. This rapid and sustained increase in transcription was inhibited by the transcriptional inhibitor actinomycin D (10 µM). Treatment with actinomycin D was also able to prevent the M 3 -muscarinic receptor anti-apoptotic effects suggesting that However, what was not clear from these experiments was the specific protein that was under transcriptional regulation. Apoptosis in certain cells has been shown to correlate with changes in Bcl-2 protein expression [27, 28] . In CHO-M 3 cells etoposide-mediated apoptosis resulted in a fall in the prosurvival Bcl-2 protein which correlated with an increase in caspase-3 activity. We therefore tested whether stimulation of the M 3 -muscarinic receptor was able to regulate the level of Bcl-2 protein. It was found that the fall in Bcl-2 levels observed following treatment with etoposide was significantly attenuated by stimulation of the M 3 -muscarinic receptor (Figure 3 ). These observations prompted us to speculate that the M 3 -muscarinic receptor was able to mediate protection from apoptotic cell death in CHO-M 3 cells by upregulation of the anti-apoptotic Bcl-2 protein.
Role of the poly-basic region in the C-terminal tail of the G q/11 -coupled muscarinic receptors
The truncation mutant 565-M 3 lacking the ability to mediate an anti-apoptotic response indicated an essential role for the C-terminal tail in coupling to the survival signalling pathway. Furthermore, the fact that only the G q/11 -coupled members of the muscarinic receptor family were able to mediate cell survival in CHO cells indicated that a structural feature present exclusively in the C-terminal tail of the G q/11 -coupled receptor subtypes was essential in coupling muscarinic receptors to the cell-survival pathway. Sequence comparison of the C-terminal tail revealed that immediately downstream of the putative cysteine palmitoylation site is a poly-basic region which is conserved exclusively amongst the G q/11 -coupled muscarinic receptor family. Mutation of the arginines and lysines within this region (Lys 565 -Lys 570 ) to alanines in the M 3 -muscarinic receptor resulted in a receptor that was unable to mediate protection against etoposideinduced cell death [20] . Whether this region is important in recruiting an adaptor protein that is involved in coupling the receptor to the pro-survival pathway is currently being investigated.
Conclusions
Our studies have revealed that the G q/11 -coupled muscarinic receptors expressed in CHO cells are able to protect cells from apoptotic cell death mediated by DNA damage. This protective mechanism proceeds via a signalling pathway that is distinct from the MAP kinase, PI 3-kinase/Akt and G q/11 /PLC signalling pathways. The activation of the survival pathway is, however, dependent on structural elements within the C-terminal tail of the receptors and appears to be focused to a poly-basic region that is conserved among the G q/11 -coupled receptor subtypes. The mechanism of muscarinic receptor-mediated cell survival is also dependent on the ability of the muscarinic receptors to mediate transcription and correlated with the muscarinic receptor up-regulation of the anti-apoptotic Bcl-2 protein.
This study and many others have now established that GPCRs can regulate apoptosis. The major challenge will be to link these observations with physiologically relevant scenarios where GPCRs may well play a key role in determining the fate of specific cell populations in intact tissues.
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